Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system
Open accessThe DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Abstract
Background: Cancer treatment with a variety of chemotherapeutic agents often is associated with delayed adverse neurological consequences. Despite their clinical importance, almost nothing is known about the basis for such effects. It is not even known whether the occurrence of delayed adverse effects requires exposure to multiple chemotherapeutic agents, the presence of both chemotherapeutic agents and the body's own response to cancer, prolonged damage to the blood-brain barrier, inflammation or other such changes. Nor are there any animal models that could enable the study of this important problem. Results: We found that clinically relevant concentrations of 5-fluorouracil (5-FU; a widely used chemotherapeutic agent) were toxic for both central nervous system (CNS) progenitor cells and non-dividing oligodendrocytes in vitro and in vivo. Short-term systemic administration of 5-FU caused both acute CNS damage and a syndrome of progressively worsening delayed damage to myelinated tracts of the CNS associated with altered transcriptional regulation in oligodendrocytes and extensive myelin pathology. Functional analysis also provided the first demonstration of delayed effects of chemotherapy on the latency of impulse conduction in the auditory system, offering the possibility of non-invasive analysis of myelin damage associated with cancer treatment. Conclusions: Our studies demonstrate that systemic treatment with a single chemotherapeutic agent, 5-FU, is sufficient to cause a syndrome of delayed CNS damage and provide the first animal model of delayed damage to white-matter tracts of individuals treated with systemic chemotherapy. Unlike that caused by local irradiation, the degeneration caused by 5-FU treatment did not correlate with either chronic inflammation or extensive vascular damage and appears to represent a new class of delayed degenerative damage in the CNS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 CNS progenitor cells are vulnerable to clinically relevant levels of 5-FU exposure. (a) A summary of the putative relationships between the different cell types under study (for discussion of this and alternative views on lineage relationships in the CNS, see [199,200]). Pluripotent neuroepithelial stem cells (NSC) give rise to glial restricted precursor (GRP) cells and neuron restricted precursor (NRP) cells. GRP cells in turn give rise to astrocytes and oligodendrocyte-type-2 astrocyte progenitor/oligodendrocyte precursor cells (O-2A/OPCs), the ancestors of oligodendrocytes. (b,c) Primary CNS cells (b) or various cancer cell lines (c) were grown on coverslips and exposed to 5-FU for 24 h before analysis of cell viability as described in Materials and methods. 5-FU concentrations were chosen on the basis of drug concentrations reached in humans after conventional 5-FU treatment. None of the tumor lines tested were sensitive to 5-FU treatment in this dose range, whereas O-2A/OPCs, oligodendrocytes, GRP cells and human umbilical vein endothelial cells (HUVECs) were sensitive. (d,e) Exposure conditions designed to mimic the exposure levels associated with long-term infusion (d) or high-dose bolus administration (e) yielded similar results, with vulnerability of O-2A/OPCs and non-dividing oligodendrocytes to 5-FU exceeding the vulnerability of rapidly dividing cancer cells. As shown in (b,d), the vulnerability of HUVECs also exceeds the vulnerability of cancer cells. Each experiment was carried out in quadruplicate and was repeated at least twice in independent experiments. Data represent mean of survival ± s.e.m, normalized to control values.](https://figures.cochat.ai/paper-figures/1e1e4baf61204ebcbcfb8ba9503ec507/systemic-5-fluorouracil-treatment-causes-a-syndrome-of-delayed-myelin-figure-1.jpg)










Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The mainstay of CRC treatment, 5‐fluorouracil, has several side effects, including toxicity to both central nervous system progenitor cells and oligodendrocytes, even in the short term, limiting its long‐term clinical use [31, 32].”
From Synergistic Potential of Argentatins A and B to Improve 5‐Fluorouracil Cytotoxicity in Colorectal Cancer Cell Models (2024) · cites this paper as [32]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subventricular zone astrocytes are neural stem cells in the adult mammalian brain
Doetsch, F., Caillé, I., Lim, D. A., García-Verdugo, J. M., & Alvarez-Buylla, A. (1999) · Cell · doi:10.1016/s0092-8674(00)80783-7 · Cited by 3,898 · cited 20×
“In the SVZ, 5-FU exposure was associated with a 40.9 ± 2.6% decrease in numbers of BrdU+ cells on day 1, with a transient re-population of BrdU+ cells at days 7 and 14, followed by a subsequent decrease in animals examined at day 56 and 6 months after completion of treatment.”
BackgroundMethodInfluentialInflammatory Blockade Restores Adult Hippocampal Neurogenesis
Monje, M. L., Toda, H., & Palmer, T. D. (2003) · Science · doi:10.1126/science.1088417 · Cited by 2,426
Raff, M. C., Miller, R. H., & Noble, M. (1983) · Nature · doi:10.1038/303390a0 · Cited by 2,030
Self-citationF4/80, a monoclonal antibody directed specifically against the mouse macrophage
Austyn, J. M., & Gordon, S. (1981) · European Journal of Immunology · doi:10.1002/eji.1830111013 · Cited by 1,579
Transient expression of doublecortin during adult neurogenesis
Brown, J. P., Couillard‐Després, S., Cooper‐Kuhn, C. M., Winkler, J., Aigner, L., & Kuhn, H. G. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10874 · Cited by 1,496
Neurogenesis in Adult Subventricular Zone
Alvarez-Buylla, A., & Garcı́a-Verdugo, J. M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-03-00629.2002 · Cited by 1,466
Freireich, E. J., Gehan, E. A., Rall, D. P., Schmidt, L. H., & Skipper, H. E. (1966) · PubMed · Cited by 1,382
Irradiation induces neural precursor-cell dysfunction
Monje, M. L., Mizumatsu, S., Fike, J. R., & Palmer, T. D. (2002) · Nature Medicine · doi:10.1038/nm749 · Cited by 1,271
Clinical Pharmacology of 5-Fluorouracil
Diasio, R. B., & Harris, B. E. (1989) · Clinical Pharmacokinetics · doi:10.2165/00003088-198916040-00002 · Cited by 969
Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease
Bartzokis, G. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.03.001 · Cited by 968
Research works printed but not linked: 3
- Silverman DH, Dy CJ, Castellon SA, Lai J, Pio BS, Abraham L, Waddell K, Petersen L, Phelps ME, Ganz PA: Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5–10 years after chemotherapy. Breast Cancer Res Treat. 2007, 103: 303-311. 10.1007/s10549-006-9380-z. · DOI · Paper page
- Raimondi AJ, Tomita T: Advantages of 'total' resection of medulloblastoma and disadvantages of full head postoperative radiation therapy. Childs Brain. 1979, 5: 550-551.
- Cankaya H, Oner AF, Egeli E, Caksen H, Uner A, Akcay G: Auditory brainstem response in children with iron deficiency anemia. Acta Paediatr Taiwan. 2003, 44: 21-24.
Cited by
Items 201–300 of 317
Radiation, chemotherapy, and symptom management in cancer-related cognitive dysfunction
Loiselle, C. R., & Rockhill, J. K. (2009) · Current Pain and Headache Reports · doi:10.1007/s11916-009-0043-8 · Cited by 6
Narimane, S., Elghissassi, I., Bellahammou, K., Lakhdissi, A., M’rabti, H., & Errihani, H. H. (2014) · Case Reports in Oncological Medicine · doi:10.1155/2014/391256 · Cited by 6
Developing translational animal models of cancer-related fatigue
Meagher, M. W. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511780868.016 · Cited by 6
Sánchez‐Olivares, P., Silva‐Nolasco, A. M., de la Cruz‐Morcillo, M. A., García‐Martínez, M. M., Pinedo‐Serrano, A., Carmona, M., & Galán‐Moya, E. M. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70294 · Cited by 5
Proposed key characteristics of neurotoxic chemicals
Lein, P. J., Bowman, A. B., Cao, Z., Carson, M. J., Eskenazi, B., Fritsche, E., Harry, G. J., Härtung, T., Pessah, I. N., Slikker, W., et al. (2025) · NeuroToxicology · doi:10.1016/j.neuro.2025.103370 · Cited by 7
Haller, O. J., Semendric, I., Collins‐Praino, L. E., Whittaker, A. L., & George, R. P. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115391 · Cited by 6
Cognitive Dysfunction, Mood Disorders, and Fatigue as Complications of Cancer
Dietrich, J., & Parsons, M. W. (2017) · Springer eBooks · doi:10.1007/978-3-319-57901-6_12 · Cited by 5
Self-citationLife after Cell Death—Survival and Survivorship Following Chemotherapy
McErlain, T., Burke, A., & Branco, C. M. (2021) · Cancers · doi:10.3390/cancers13122942 · Cited by 6
Exploring marine Lactobacillus and its protein for probiotic-based oral cancer therapy
Vidya, S. L., Thiruneelakandan, G., Krishnamoorthy, R., Subbarayan, S., Maran, B. A. V., Alshuniaber, M. A., Gatasheh, M. K., Sunday, B. Y., & Ahmad, A. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.127652 · Cited by 8
Why, after Chemotherapy, is it Necessary to Assess Memory Using Translational Testing?
Acevedo, S. F. (2012) · Breast Cancer Basic and Clinical Research · doi:10.4137/bcbcr.s10293 · Cited by 5
5-Fluorouracil for keloid scars
Rabey, N. G., Goldie, S. J., & Price, R. D. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012792 · Cited by 6
Cognitive functions of children with brain tumor in the treatment process
Önal, G., & Huri̇, M. (2020) · British Journal of Occupational Therapy · doi:10.1177/0308022620941396 · Cited by 5
Neurocognitive Effects of Primary Brain Tumors
Abu‐Hegazy, M., & El-Hadaad, H. A. (2016) · InTech eBooks · doi:10.5772/62924 · Cited by 7
Scatchard, K., & Lee, S. M. (2010) · Blue books of neurology · doi:10.1016/b978-0-7506-7516-1.00016-5 · Cited by 5
Pesendorfer, L. M., & Zimmer, P. (2016) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.1000417 · Cited by 5
Potential connections between senescence and chemobrain: An early overview of literature
Melhem, N. Y., Qutifan, S., Alsalem, M., & Saleh, T. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102896 · Cited by 5
Cancer-Related Cognitive Impairment: Diagnosis, Pathogenesis, and Management
Moreno, A. M., Hamilton, R. A., & Currier, M. B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-72166-0.00020-7 · Cited by 5
Cognitive function in cancer survivors
Vardy, J. L., & Dhillon, H. M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1015-1.00043-6 · Cited by 4
Protective Effects of Naringin on Lung Toxicity Induced by 5-Fluorouracil in Rats
Gedikli, S., & Erbaş, E. (2020) · Kocatepe Veterinary Journal · doi:10.30607/kvj.782356 · Cited by 5
Capecitabine-related neurotoxicity presenting with agraphia
İşçan, D., Tolay, R., Bayram, E., Demir, T., & Bıçakçı, Ş. (2022) · Journal of Oncology Pharmacy Practice · doi:10.1177/10781552221116329 · Cited by 4
Mini-review: Aplastic myelin following chemotherapy
Savchuk, S., & Monje, M. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136861 · Cited by 4
Iatrogenic Neuropathology of Systemic Therapies
Torre, M., & Feany, M. Β. (2020) · Surgical pathology clinics · doi:10.1016/j.path.2020.01.004 · Cited by 3
Reduced Fusiform Gyrus Activation During Face Processing in Pediatric Brain Tumor Survivors
Hocking, M. C., Schultz, R. T., Minturn, J. E., Brodsky, C., Albee, M. V., & Herrington, J. D. (2021) · Journal of the International Neuropsychological Society · doi:10.1017/s135561772100117x · Cited by 6
Cancer, Chemotherapy and Cognitive Dysfunction
Dietrich, J., & Kaiser, J. (2016) · touchREVIEWS in Neurology · doi:10.17925/usn.2016.12.01.43 · Cited by 4
Self-citationAl-Hamdany, M. Z., & Al-Hubaity, A. Y. (2014) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 4
Peterson, B. M. (2015) · Scholarship & Creative Works - Digital UNC a service of University Libraries (University of Northern Colorado) · Cited by 4
Cancer treatment–related cognitive impairment
Neth, B. J., Schagen, S. B., & Wefel, J. S. (2026) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdag064 · Cited by 5
Neurologic Complications of Oncologic Therapy
Arrillaga‐Romany, I., Monje, M., & Wen, P. Y. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800945-1.00015-x · Cited by 3
Bajic, J. E., Howarth, G. S., Mashtoub, S., Whittaker, A. L., Bobrovskaya, L., & Hutchinson, M. R. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24959 · Cited by 3
Age-Dependent Cellular and Behavioral Deficits Induced by Molecularly Targeted Drugs Are Reversible
Scafidi, J., Ritter, J., Talbot, B. M., Edwards, J., Chew, L., & Gallo, V. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2254 · Cited by 3
Permanent lesion to the corticospinal tract after therapy with capecitabine
Wagner‐Altendorf, T. A., Heldmann, M., Hanßen, H., & Münte, T. F. (2019) · BMJ Case Reports · doi:10.1136/bcr-2019-231248 · Cited by 3
Lambertini, M., Aftimos, P. G., Gombos, A., Awada, A. H., & Piccart, M. J. (2018) · Springer eBooks · doi:10.1007/978-3-319-70253-7_2 · Cited by 4
Cognitive dysfunction: is chemobrain real?
Meyers, C. A., & Wefel, J. S. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511780868.009 · Cited by 3
Gayer, C. C. (2013) · UKnowledge (University of Kentucky) · Cited by 2
Ullah, M., Rahman, A., & Dutta, S. (2015) · International Journal of Advances in Pharmaceutical Analysis · doi:10.7439/ijapa.v5i1.1592 · Cited by 2
Déficits neuropsicológicos asociados a alteraciones cerebrales secundarias a tratamiento oncológicos
Gómez-Cruz, M. (2012) · Psicooncología · doi:10.5209/rev_psic.2011.v8.n2-3.37878 · Cited by 7
Vearncombe, K., & Pachana, N. A. (2009) · Australian Psychologist · doi:10.1080/00050060903096652 · Cited by 2
Seizures following subconjunctival 5-FU therapy
Höhn, R., Lamparter, J., Pfeiffer, N., & Vossmerbaeumer, U. (2010) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-010-1361-6 · Cited by 2
Amelioration of 5-FU induced toxicity by using RF under white light: An in vitro study
Larramendy, M. L., & National University of La Plata (2015) · Integrative Pharmacology Toxicology and Genotoxicology · doi:10.15761/iptg.1000108 · Cited by 2
Smith, D. A., Somarouthu, B., & Ramaiya, N. H. (2019) · Abdominal Radiology · doi:10.1007/s00261-019-01954-z · Cited by 2
Cardiovascular and Central Nervous System Toxicity by Anticancer Drugs in Breast Cancer Patients
Natale, G., & Bocci, G. (2020) · Springer eBooks · doi:10.1007/978-3-030-28008-6_50 · Cited by 2
The effect of doxorubicin or cyclophosphamide treatment on auditory brainstem response in mice
Hennings, M. A., & Fremouw, T. (2022) · Experimental Brain Research · doi:10.1007/s00221-022-06463-y · Cited by 2
Re: Neurocognitive Functioning in Adult Survivors of Childhood Noncentral Nervous System Cancers
Morelli, A. M., Ravera, S., & Panfoli, I. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr032 · Cited by 2
Singh, A. K., Ruiz, D., Rasheed, M. S. U., Avery, T. D., Turner, D. J. L., Abell, A. D., & Grace, P. M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.10.598291 · Cited by 2
Chemobrain in Cancer Treatment: Mechanisms and Its Prevention
Ongnok, B., Thiankhaw, K., Chattipakorn, N., & Chattipakorn, S. C. (2022) · Springer eBooks · doi:10.1007/978-3-030-80962-1_352-1 · Cited by 2
Potential Pathways for Chemotherapy-Induced Cognitive Decline
Dahiya, M., Yadav, M., Sharma, P., Joon, P., & Kumar, A. (2023) · Springer eBooks · doi:10.1007/978-981-99-2196-6_60-1 · Cited by 1
Yaniv, D., Niccolai, L. M., Wefel, J. S., Sullaway, C. M., Phan, J., Fuller, C. D., Haroun, K. B., Hanna, E. Y., & Su, S. Y. (2023) · Journal of Neurological Surgery Part B Skull Base · doi:10.1055/s-0043-1775753 · Cited by 1
Chemotherapeutics Associated Central Nervous System Toxicity: Mechanistic Insights
Chib, S., Dutta, B. J., Seksaria, S., Amanat, M., & Singh, R. (2025) · Current Cancer Therapy Reviews · doi:10.2174/0115733947386278250619072923 · Cited by 1
Enhanced anticancer activity of novel pyrimidine nucleoside analog in pancreatic cancer
Bulusu, R., Okoro, J. C., Frimpong, E., Krishnan, S., Yoon, S. L., Han, B., Xue, Z., & Agyare, E. (2025) · American Journal of Cancer Research · doi:10.62347/arcz1924 · Cited by 1
Chemotherapy-Induced Brain Damage: Mechanisms and Insights from Rodent Models
Veljković, M., Džopalić, T., Randjelović, P. J., Dragonjić, L. P., Milenković, J., & Ilić, I. (2026) · Brain Sciences · doi:10.3390/brainsci16070750 · Cited by 1
TCF7L2 activation is required for myelin regeneration in 5-FU-induced demyelinating mice
Tan, B., Wang, J., Zhao, M., Hu, Y., Wang, J., Yang, B., He, Q., Yang, X. C., & Weng, Q. (2015) · Toxicology Research · doi:10.1039/c5tx00110b · Cited by 1
Chemo-Gehirn: Nebenwirkungen von Chemotherapie im Erleben, Denken, Fühlen und Handeln
Spitzer, M. (2014) · Nervenheilkunde · doi:10.1055/s-0038-1633398 · Cited by 1
Acevedo, S. F. (2013) · Journal of Womens Health Issues and Care · doi:10.4172/2325-9795.1000117 · Cited by 1
Capecitabine-induced Leukoencephalopathy Presenting with Signs of Transient Ischemic Attack
Eliaçık, S., Aykaç, S., & Tan, F. U. (2021) · Turkish Journal Of Neurology · doi:10.4274/tnd.2021.10179 · Cited by 1
Crucitta, S., Sciandra, F., Cerbioni, A., Cucchiara, F., Arici, R., Rafaniello, C., Capuano, A., van Schaik, R. H., Danesi, R., & Re, M. D. (2021) · Annals of Research in Oncology · doi:10.48286/aro.2021.09 · Cited by 1
Aftimos, P. G., Gombos, A., Pugliano, L., Awada, A. H., & Piccart, M. J. (2012) · Springer eBooks · doi:10.1007/978-0-85729-787-7_2 · Cited by 2
Neurologic complications of oncologic therapy
Budhu, J. A., Wen, P. Y., & Lee, E. Q. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822835-7.00013-5 · Cited by 2
5-Fluorouracil Ameliorates the Hematotoxicity Induced by Cyclophosphamide in Male Albino Rats
Yahya, R. A. M., Azab, A. E., Attia, A. M., Yehia, M. A., & El.M.Shkal, K. (2022) · Trends journal of sciences research · doi:10.31586/ujpp.2022.453 · Cited by 1
Sudhakar, K., & Ramesh, M. (2014) · International Journal of Pharma and Bio Sciences · Cited by 1
Central Nervous System Complications in Patients Undergoing Chemotherapy
Psimaras, D., Leclercq, D., Ricard, D., & Delattre, J. (2014) · Medical radiology · doi:10.1007/174_2014_1050 · Cited by 1
Aung, H. M., Huangteerakul, C., Panvongsa, W., Jensen, A. N., Chairoungdua, A., Sukrong, S., & Jensen, L. T. (2018) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2018.05.016 · Cited by 1
Ganai, S. A. (2020) · Springer eBooks · doi:10.1007/978-981-15-8179-3_6 · Cited by 1
Jain, K. K. (2021) · Springer eBooks · doi:10.1007/978-3-030-73503-6_13 · Cited by 1
Gamification as a Solution for Cancer-Induced Cognitive Impairment
Vatansever, G., KEÇELİ, T., Kırca, Ö., Başarır, A. C., & Özdoğan, M. (2021) · Journal of Oncological Sciences · doi:10.37047/jos.2020-78809 · Cited by 1
Yamaguchi, Y., Saito, T., Takagi, M., Nakazawa, T., & Tamura, K. (2022) · Journal of Toxicologic Pathology · doi:10.1293/tox.2022-0003 · Cited by 1
Barras, M., Schmitz, L., Braumann, C., Uhl, W. H., Skrygan, M., Buchholz, M., Meyer, T., Stockfleth, E., Müller, T. H., Becker, J. C., et al. (2023) · Dermato · doi:10.3390/dermato3010007 · Cited by 1
Pharmacogenomics of chemotherapy induced cognitive dysfunction
AlEjielat, R. (2013) · doi:10.17077/etd.n7km95tr · Cited by 1
Rocke, M., Knochenhauer, E., Thams, F., Antonenko, D., Fromm, A., Jansen, N., Grittner, U., Schmidt, S., Brakemeier, E., & Floeel, A. (2022) · medRxiv · doi:10.1101/2022.04.04.22273380 · Cited by 1
Yamada, T. H. (2011) · doi:10.17077/etd.0rmsjh58 · Cited by 5
Sugar Consumption and Cognitive Aging in the Swedish Adoption/Twin Study of Aging
Seetharaman, S. (2012) · Digital Commons - University of South Florida (University of South Florida)
ELBeltagy, M. (2010) · Nottingham ePrints (University of Nottingham)
Schagen, S. B., Boogerd, W. J., Eisel, U. L. M., & Buwalda, B. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr033
Koppelmans, V., Breteler, M. M. B., Mc, E., de Ruiter, M. B., Schagen, S. B., van der Lijn, F., van der Lugt, A., Vrooman, H. A., Niessen, W. J., Boogerd, W. J., et al. (2012)
Effects of cancer therapies on the brain : from molecular mechanisms to behavioral outcomes
Kovalchuk, A. (2015) · Open ULeth Scholarship (OPUS) (University of Lethbridge)
Histone deacetylase inhibition-mediated cytotoxicity of oligodendrocytes.
Dincman, T. A. (2011) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/351
The Current State and Future Prospects of Multidrug- Resistance in Cancer Cells
Chin, S. R. (2010) · e-scholar@UOIT (University of Ontario Institute of Technology)
Encefalopatía inducida por 5-fluorouracilo: Un mismo agente, dos entidades diferentes
Velásquez, J. C., González, D. M., Pinilla, P. A., Rodríguez, C. A., & Bruges, R. E. (2015) · Acta Médica Colombiana · doi:10.36104/amc.2015.593
Histopathologische Veränderungen im zentralen Nervensystem nach peripherer Stammzelltransplantation
Knust, E. (2016) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5534
Fonctions cognitives après cancer : quelles réalités ?
Noal, S., Daireaux, A., & Joly, F. (2010) · La Lettre du cancérologue
A Role for Orexin Neuron Activity in Cytotoxic Chemotherapy-Induced Fatigue
Weymann, K. B. (2013) · doi:10.6083/m4n29vnp
A Study of Chemotherapy-Related Cognitive Impairment in Gynecologic Cancer Patients
Chen, Z., Zhang, R., Zhang, X., Li, Y., Chen, B., Yuan-yue, Z., & Zhou, R. (2016)
Chemotherapy, estrogen, and cognition : neuroimaging and genetic variation
Conroy, S. K. (2014) · IUScholarWorks (Indiana University) · doi:10.7912/c2/2053 · Cited by 1
Neurological Complications of Cancer and Cancer Therapies in Long-Term Survivors
Arrillaga, I. (2017) · Springer eBooks · doi:10.1007/978-3-319-57901-6_34
Molecular insights into the effects of cancer and chemotherapy on the brain
Kovalchuk, A. (2017) · Cited by 1
„Chemobrain“ – Stand der Forschung und Implikationen für die klinische Neuropsychologie
Dannecker, N., Bürgi, N., & Brugger, P. C. (2019) · Zeitschrift für Neuropsychologie · doi:10.1024/1016-264x/a000247
5-Fluorouracil toxicosis in cats and dogs
Bates, N. (2019) · Companion animal · doi:10.12968/coan.2019.24.6.288
A Study of Chemotherapy-Related Cognitive Impairment in Gynecologic Cancer Patients
陈, 志. (2016) · Medical Diagnosis · doi:10.12677/md.2016.61008
Eskandari, A., Kesmati, M., & Rezaie, A. (2019) · DOAJ (DOAJ: Directory of Open Access Journals)
Neurocognitive Toxicity from Radiation Therapy for Brain Metastases
Feghali, K. A. A., Chung, C. D., Wefel, J. S., & Bradshaw, M. E. (2019) · Springer eBooks · doi:10.1007/978-3-030-23417-1_25
Long Term Effects of Chemotherapy on Cognition, Preventative Potential of Antidepressants
Hall, R. (2014) · DigitalCommons (California Polytechnic State University)
Neurocognitive Effects of Brain Metastases and Their Treatment
Feghali, K. A. A., Bradshaw, M. E., Chung, C. D., & Wefel, J. S. (2020) · Springer eBooks · doi:10.1007/978-3-030-42958-4_29
Michels, B. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8414
Kameo, S. Y., Lima, R. B., Duarte, J. L., Amorim, B. F., Silva, G. M., Marinho, P. M. L., & Sawada, N. O. (2021) · REVISTA CIÊNCIAS EM SAÚDE · doi:10.21876/rcshci.v11i1.1089
Cellular senescence in the ageing brain: to eliminate or not to eliminate?
Talma, N. (2022) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.206630102
Knight, S., Smith, D., & Armstrong, C. L. (2018) · Springer eBooks · doi:10.1007/978-3-319-57111-9_9027
Knight, S., Smith, D., & Armstrong, C. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-56782-2_9027-1
Cardiovascular and Central Nervous System Toxicity by Anticancer Drugs in Breast Cancer Patients
Natale, G., & Bocci, G. (2019) · Springer eBooks · doi:10.1007/978-3-319-90305-7_50-1
Delayed myelin destruction underlies late CNS damage after chemotherapy
(2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0843
de Boer, C. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9420
Metadata
- Authors
- Han, R., Yang, Y. M., Dietrich, J., Luebke, A., Mayer-Pröschel, M., & Noble, M.
- Affiliations
- University of Rochester Medicine (US)
- Corresponding author
- Noble, Mark
- Venue
- Journal of Biology
- Published
- 2008-04-22
- Volume
- 7
- Issue
- 4
- Pages
- 12-12
- ISSN
- 1475-4924 (ISSN-L)
- PMC
- PMC2397490
- OpenAlex
- W2152709121
- Cited by
- 316
- References
- 203
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 8 · 2023: 10 · 2022: 21 · 2021: 22 · 2020: 20 · 2019: 16 · 2018: 17 · 2017: 14 · 2016: 25 · 2015: 16 · 2014: 26 · 2013: 25 · 2012: 18
- FWCI
- 18.67
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0/ (tdm)
- creativecommons.org/licenses/by/2.0/ (vor)
- Locations
- Journal of Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Institute on Deafness and Other Communication Disorders (R01DC003086)
- National Institute of Neurological Disorders and Stroke (R01NS044701, NS44701)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD39702, R01HD039702)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Health Sciences › Medicine › Oncology › Cancer Treatment and Pharmacology
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- 5-fluorouracil, chemotherapy-induced neurotoxicity, white matter degeneration, myelin pathology, transcriptional regulation, auditory system, central nervous system
- MeSH terms
- Action Potentials, Animals, Antineoplastic Agents, Auditory Pathways, Bromodeoxyuridine, Central Nervous System, Fluorouracil, Humans, Indoles, Microscopy, Fluorescence, Myelin Sheath, Stem Cells, Tetrazolium Salts, Thiazoles, In Situ Nick-End Labeling, Cell Line, Tumor, Microscopy, Electron, Transmission, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.